Tixylix Chesty Cough 50mg/5ml oral solution

Pays: Royaume-Uni

Langue: anglais

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Achète-le

Ingrédients actifs:

Guaifenesin

Disponible depuis:

Haleon UK Ltd

Code ATC:

R05CA03

DCI (Dénomination commune internationale):

Guaifenesin

Dosage:

10mg/1ml

forme pharmaceutique:

Oral solution

Mode d'administration:

Oral

classe:

No Controlled Drug Status

Type d'ordonnance:

Valid as a prescribable product

Descriptif du produit:

BNF: 03090200; GTIN: 5051562013101

Résumé des caractéristiques du produit

                                OBJECT 1
TIXYLIX CHESTY COUGH
Summary of Product Characteristics Updated 05-Aug-2013 |
GlaxoSmithKline Consumer Healthcare
1. Name of the medicinal product
Tixylix
®
Chesty Cough
2. Qualitative and quantitative composition
Each 5ml contains Guaifenesin 50mg
For excipients see section 6.1
3. Pharmaceutical form
Linctus
A clear, colourless or straw coloured solution
4. Clinical particulars
4.1 Therapeutic indications
Expectorant for the symptomatic relief of acute productive (chesty)
cough.
The linctus is for the lubrication and relief of the sore throat and
hoarseness, which may be associated
with the cough.
4.2 Posology and method of administration
The following dose is taken 4 hourly. Do not exceed 6 doses in 24
hours.
Tixylix Chesty Cough is contra-indicated in children under 6 years of
age.
6 – 10 years 5 to 10ml
Not to be used for more than 5 days without the advice of a doctor.
Parents or carers should seek medical
advice if the child's condition deteriorates during treatment.
Do not exceed the stated dose.
Keep out of the sight and reach of children.
4.3 Contraindications
Hypersensitivity to the active ingredients or to any of the
excipients.
Not to be used in children under 6 years of age.
4.4 Special warnings and precautions for use
Consult a doctor before use if suffering from an acute asthma attack,
a chronic cough or are asthmatic.
Stop use and consult a healthcare professional if the cough persists
for longer than 5 days.
Stop use and consult a healthcare professional if the cough is
accompanied by a fever, rash or persistent
headache or is recurrent.
If symptoms persist, consult a doctor.
Keep out of the sight and reach of children.
Do not exceed the stated dose.
Do not take with any other cough and cold medicine, including cough
suppressants.
4.5 Interaction with other medicinal products and other forms of
interaction
Should not be taken with a cough suppressant.
If urine is collected within 24 hours of a dose of Tixylix Chesty
Cough a metabolite of guaifenesin may
cause a colour interference with
                                
                                Lire le document complet
                                
                            

Rechercher des alertes liées à ce produit